סרטיקן ® 0.25 מ"ג טבליות מסיסות

Država: Izrael

Jezik: hebrejski

Izvor: Ministry of Health

Aktivni sastojci:

EVEROLIMUS 0.25 MG

Dostupno od:

NOVARTIS PHARMA SERVICES AG

ATC koda:

L04AA18

Farmaceutski oblik:

TABLETS DISPERSIBLE

Administracija rute:

PER OS

Proizveden od:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Terapijska grupa:

EVEROLIMUS

Terapijske indikacije:

Kidney and heart transplantationCertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.

Datum autorizacije:

2010-02-01